Citation: Y. Murawaki et al., Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels, HEPATOL RES, 21(1), 2001, pp. 67-75
Authors:
Murawaki, Y
Ikuta, Y
Okamoto, K
Koda, M
Kawasaki, H
Citation: Y. Murawaki et al., Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C, J GASTRO, 36(6), 2001, pp. 399-406
Authors:
Okamoto, K
Murawaki, Y
Yuasa, I
Kawasaki, H
Citation: K. Okamoto et al., Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workers, ALC CLIN EX, 25(6), 2001, pp. 19S-23S
Citation: K. Okada et al., Changes in esophageal variceal pressure after transcatheter arterial embolization for hepatocellular carcinoma, ENDOSCOPY, 33(7), 2001, pp. 595-600
Authors:
Koda, M
Murawaki, Y
Mitsuda, A
Oyama, K
Okamoto, K
Idobe, Y
Suou, T
Kawasaki, H
Citation: M. Koda et al., Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma - A randomized control study, CANCER, 92(6), 2001, pp. 1516-1524
Authors:
Kobayashi, T
Murawaki, Y
Reddy, PS
Abe, M
Fujii, N
Citation: T. Kobayashi et al., Molecular imprinting of caffeine and its recognition assay by quartz-crystal microbalance, ANALYT CHIM, 435(1), 2001, pp. 141-149
Authors:
Murawaki, Y
Kobayashi, M
Koda, M
Kawasakia, H
Citation: Y. Murawaki et al., Effects of lactulose on intestinal bacterial flora and fecal organic acidsin patients with liver cirrhosis, HEPATOL RES, 17(1), 2000, pp. 56-64
Citation: M. Koda et al., Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases, J GASTR HEP, 15(12), 2000, pp. 1424-1429
Authors:
Koda, M
Tanaka, H
Murawaki, Y
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Liver perforation: A serious complication of percutaneous acetic acid injection for hepatocellular carcinoma, HEP-GASTRO, 47(34), 2000, pp. 1110-1112
Authors:
Koda, M
Murawaki, Y
Mitsuda, A
Ohyama, K
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma, CANCER, 88(3), 2000, pp. 529-537
Authors:
Koda, M
Murawaki, Y
Idobe, Y
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Is choledocholithiasis a late complication of nonresectional therapies forhepatocellular carcinoma?, HEP-GASTRO, 46(30), 1999, pp. 3091-3094
Authors:
Murawaki, Y
Yamada, S
Ikuta, Y
Kawasaki, H
Citation: Y. Murawaki et al., Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease, J HEPATOL, 30(6), 1999, pp. 1090-1098
Citation: Y. Murawaki et al., Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1, CLIN CHIM A, 281(1-2), 1999, pp. 109-120